Alzheimer's disease Trials in San Diego, United States
Conditions / Alzheimer's disease / San Diego, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
82 total trials for this combination
Showing top 10 of 82 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01767311 | A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease | COMPLETED | PHASE2 |
| NCT02783573 | A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia | TERMINATED | PHASE3 |
| NCT04241068 | A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 | TERMINATED | PHASE3 |
| NCT00574132 | Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) | COMPLETED | PHASE3 |
| NCT06653153 | A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02956486 | A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT01127633 | Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT01900665 | Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo | TERMINATED | PHASE3 |
| NCT00575055 | Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) | COMPLETED | PHASE3 |
| NCT00937352 | A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease | TERMINATED | PHASE3 |